Molecular Evidence of Coinfection with Acute Respiratory Viruses and High Prevalence of SARS-CoV-2 among Patients Presenting Flu-Like Illness in Bukavu City, Democratic Republic of Congo
Table 2
Association of flu-like symptoms with SARS-CoV-2 positivity among flu-like patients seeking treatment in different health facilities.
Variables
Negative covid19. N = 1164 (%)
Positive Covid19. N = 188 (%)
Or (CI)
value
Symptoms (%)
Fever
512 (44.1%)
98 (52.2%)
1.1 (0.560–2.282)
0.734
Coldness
531 (45.6%)
98 (52.2%)
0.9 (0.456–1.856)
0.816
Shivering
371 (31.9%)
88 (47.8%)
1.8 (0.88–1.35)
0.0246
Sweating
268 (23.0%)
56 (29.9%)
1.3 (0.603–3.69)
0.452
Cough
764 (65.6%)
168 (89.6%)
6.5 (2.161–28.207)
0.003
Breathing difficulties
271 (23.3%)
45 (23.9%)
0.7 (0.321–1.814)
0.590
Essoufflés
233 (20.0%)
17 (9.0%)
0.3 (0.107–1.094)
0.0992
Headaches
793 (68.1%)
146 (77.6%)
1.6 (0.738–3.821)
0.242
Asthenia
560 (56.7%)
126 (67.2%)
1.6 (0.804–3.487)
3.487
Myalgia
478 (41.1%)
112 (59.7%)
2.7 (1.363–5.859)
0.006
Anorexia
314 (27.0%)
73 (38.8%)
1.5 (0.743–3.283)
0.232
Sputum
194 (16.7%)
42 (22.4%)
0.8 (0.360–1.926)
0.716
Dyspnea
164 (14.1%)
19 (10.4%)
0.6 (0.236–1.772)
0.461
Expositions (%)
Stay in high risk areas
116 (10.0)
33 (17.9)
1.09 (0.31–2.81)
0.85
Close contact
48 (4.1)
11 (6.0)
2.40 (0.43–13.45)
0.29
Work in hospitals
81 (7.0)
17 (9.0)
1.78 (0.34–8.43)
0.46
Comorbidities (%)
HIV infection
8 (0.7)
0 (0.0)
—
—
Arterial hypertension
112 (9.6)
17 (9.0)
0.82 (0.21–2.57)
0.75
Obesity
30 (2.6)
11 (6.0)
0.76 (0.03–6.16)
0.81
Diabetes
69 (5.9)
11 (6.0)
1.17 (0.29–3.93)
0.80
Chronic respiratory dis.
26 (2.2)
3 (1.5)
0.56 (0.02–3.97)
0.61
Cardio pathology
8 (0.7)
0 (0.0)
—
—
Chronic kidney dis.
13 (1.1)
0 (0.0)
—
—
Nero pathology
5 (0.4)
1.5
0.00 (0.00–0.001)
0.98
Highly significant; very significant; significant.
